Services
Expertises
Resources
Who we are
Closed

Funding for Company-driven RNA Innovation (AReNA)

Supports company-driven RNA innovation

Source change captured

Funding available
Varies by project
Deadline
Unspecified
Location
Quebec, Canada

Overview

This program supports company-driven RNA innovation with a total budget of $3M. It aims to accelerate the commercialization of Québec biopharmaceutical innovations and strengthen company competitiveness.

At a glance

Funding available

Varies by project

Financing goals
  • Develop a new product or service
  • Conduct research and development activities
  • Launch or market a product/service

Eligible candidates

Location
  • Quebec
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
All groups
Legal structures
For-profit business

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2026
Periods: 2

Latest changes

AReNA call closed; next rounds pending

The AReNA page now says the previous call has closed and that new funding rounds and application deadlines will be announced later.

See more

The AReNA page now replaces the deadline section with Upcoming Funding Rounds and states that the previous call for proposals has closed. New funding rounds and application deadlines will be announced shortly.

Eligibility

Eligible geographic areas

  • Quebec

Activities funded

  • Development of innovative technologies for the RNA therapy sector.
  • Commercialization of Québec biopharmaceutical innovations.

How to apply

  • Step 1: Submit letter of intent
    • Send the non-selective letter of intent by March 16, 2026.
  • Step 2: Submit full application
    • Submit the complete application by March 30, 2026.
    • Send the application by email to appliquez-apply@cqdm.org.

Processing and Agreement

  • A non-selective letter of intent is submitted first.
  • Complete applications are then submitted for review.
  • Applications are sent by email to appliquez-apply@cqdm.org.

Additional information

  • The program is funded by the Ministry of Economy, Innovation and Energy (MEIE).
  • It is managed by CQDM as part of AReNA, Québec’s RNA Hub.
  • Applicants are directed to the AReNA website for full program details.

Contacts

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Funding for Company-driven RNA Innovation (AReNA) Program

What is the Funding for Company-driven RNA Innovation (AReNA)?

This program supports company-driven RNA innovation with a total budget of $3M. It aims to accelerate the commercialization of Québec biopharmaceutical innovations and strengthen company competitiveness.

Who can I contact for more information about the Funding for Company-driven RNA Innovation (AReNA)?

You can contact Quebec Consortium for Drug Discovery (CQDM) by email at appliquez-apply@cqdm.org.

Where is the Funding for Company-driven RNA Innovation (AReNA) available?

The Funding for Company-driven RNA Innovation (AReNA) program is available the province of Quebec.

Is the Funding for Company-driven RNA Innovation (AReNA) a grant, loan, or tax credit?

Funding for Company-driven RNA Innovation (AReNA) is a Grant and Funding

Who are the financial supporters of the Funding for Company-driven RNA Innovation (AReNA)?

Funding for Company-driven RNA Innovation (AReNA) is funded by Quebec Consortium for Drug Discovery (CQDM)